Prescribing cascade: calcium-channel blockers and diuretics
Insights
This study examined a common prescribing cascade involving calcium-channel blockers and diuretics in older adults with hypertension. The findings highlight potential medication-related harm and the need for improved prescribing practices in geriatric hypertension management.
Area of Science:
- Geriatric Medicine
- Cardiovascular Pharmacology
- Clinical Pharmacy
Background:
- Hypertension is a prevalent condition in older adults.
- Prescribing cascades, where a drug is initiated to treat a side effect of another drug, are a concern in geriatric polypharmacy.
- Calcium-channel blockers and diuretics are commonly prescribed for hypertension.
Purpose of the Study:
- To evaluate the frequency and impact of a specific prescribing cascade involving calcium-channel blockers and diuretics in older adults with hypertension.
- To identify the clinical outcomes associated with this prescribing cascade.
Main Methods:
- Retrospective cohort study using administrative health data.
- Inclusion of older adults (age 65+) diagnosed with hypertension.
- Analysis of medication prescribing patterns and healthcare utilization.
Main Results:
- A significant proportion of older adults with hypertension were exposed to the calcium-channel blocker and diuretic prescribing cascade.
- This cascade was associated with increased healthcare utilization and adverse events.
- Specific patterns of drug initiation and discontinuation were identified.
Conclusions:
- The evaluated prescribing cascade is common in older adults with hypertension and may lead to suboptimal care.
- Interventions aimed at optimizing antihypertensive prescribing in the elderly are warranted.
- Further research should focus on preventing and mitigating prescribing cascades in this population.
Abstract:
Review of: Savage RD, Visentin JD, Bronskill SE, et al Evaluation of a common prescribing cascade of calcium-channel blockers and diuretics in older adults with hypertension. JAMA Intern Med 2020;180:643-651.
More Related Videos
07:59Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Heart Failure Drugs: Diuretics
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
